Balincan USA, Inc.

BCNN · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$117$60$0
Short-Term Investments$0$0$0
Receivables$320$944$0
Inventory$0$0$0
Other Curr. Assets$0$0$270
Total Curr. Assets$437$1,004$270
Property Plant & Equip (Net)$0$0$0
Goodwill$0$0$0
Intangibles$1,803$1,224$0
Long-Term Investments$0$0$0
Tax Assets$0$0$0
Other NC Assets$10$10$0
Total NC Assets$1,813$1,234$0
Other Assets$0$0$0
Total Assets$2,250$2,238$270
Liabilities
Payables$1,479$652$0
Short-Term Debt$1,586$962$447
Tax Payable$0$0$0
Deferred Revenue$0$0$0
Other Curr. Liab.$5,979$0$1,260
Total Curr. Liab.$9,044$1,613$1,707
LT Debt$160$161$0
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$0$0$0
Total NC Liab.$160$161$0
Other Liabilities$0$0$0
Cap. Leases$0$0$0
Total Liabilities$9,204$1,774$1,707
Equity
Pref Stock$11$10$1
Common Stock$150$7,176$23
Retained Earnings-$7,545-$127-$23
AOCI$580$581$5,740
Other Equity-$150-$7,176-$7,178
Total Equity-$6,954$464-$1,437
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$2,250$2,238$270
Net Debt$0$1,629$1,062$447